24742402|t|Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer.
24742402|a|Germline mutations in CDKN2A and/or red hair color variants in MC1R genes are associated with an increased susceptibility to develop cutaneous melanoma or non melanoma skin cancer. We studied the impact of the CDKN2A germinal mutation p.G101W and MC1R variants on gene expression and transcription profiles associated with skin cancer. To this end we set-up primary skin cell co-cultures from siblings of melanoma prone-families that were later analyzed using the expression array approach. As a result, we found that 1535 transcripts were deregulated in CDKN2A mutated cells, with over-expression of immunity-related genes (HLA-DPB1, CLEC2B, IFI44, IFI44L, IFI27, IFIT1, IFIT2, SP110 and IFNK) and down-regulation of genes playing a role in the Notch signaling pathway. 3570 transcripts were deregulated in MC1R variant carriers. In particular, genes related to oxidative stress and DNA damage pathways were up-regulated as well as genes associated with neurodegenerative diseases such as Parkinson's, Alzheimer and Huntington. Finally, we observed that the expression signatures indentified in phenotypically normal cells carrying CDKN2A mutations or MC1R variants are maintained in skin cancer tumors (melanoma and squamous cell carcinoma). These results indicate that transcriptome deregulation represents an early event critical for skin cancer development. 
24742402	35	41	CDKN2A	Gene	1029
24742402	46	50	MC1R	Gene	4157
24742402	91	99	melanoma	Disease	MESH:D008545
24742402	104	128	non melanoma skin cancer	Disease	MESH:D012878
24742402	152	158	CDKN2A	Gene	1029
24742402	193	197	MC1R	Gene	4157
24742402	263	281	cutaneous melanoma	Disease	MESH:C562393
24742402	285	309	non melanoma skin cancer	Disease	MESH:D012878
24742402	340	346	CDKN2A	Gene	1029
24742402	365	372	p.G101W	ProteinMutation	tmVar:p|SUB|G|101|W;HGVS:p.G101W;VariantGroup:0;CorrespondingGene:1029;RS#:104894094;CorrespondingSpecies:9606;CA#:120387
24742402	377	381	MC1R	Gene	4157
24742402	453	464	skin cancer	Disease	MESH:D012878
24742402	535	543	melanoma	Disease	MESH:D008545
24742402	685	691	CDKN2A	Gene	1029
24742402	755	763	HLA-DPB1	Gene	3115;3105
24742402	765	771	CLEC2B	Gene	9976
24742402	773	778	IFI44	Gene	10561
24742402	780	786	IFI44L	Gene	10964
24742402	788	793	IFI27	Gene	3429
24742402	795	800	IFIT1	Gene	3434
24742402	802	807	IFIT2	Gene	3433
24742402	809	814	SP110	Gene	3431
24742402	819	823	IFNK	Gene	56832
24742402	938	942	MC1R	Gene	4157
24742402	1085	1111	neurodegenerative diseases	Disease	MESH:D019636
24742402	1120	1131	Parkinson's	Disease	MESH:D010300
24742402	1133	1142	Alzheimer	Disease	MESH:D000544
24742402	1147	1157	Huntington	Disease	MESH:D006816
24742402	1263	1269	CDKN2A	Gene	1029
24742402	1283	1287	MC1R	Gene	4157
24742402	1315	1333	skin cancer tumors	Disease	MESH:D012878
24742402	1335	1343	melanoma	Disease	MESH:D008545
24742402	1348	1371	squamous cell carcinoma	Disease	MESH:D002294
24742402	1468	1479	skin cancer	Disease	MESH:D012878
24742402	Association	1029	3433
24742402	Association	MESH:D012878	4157
24742402	Association	MESH:D006816	4157
24742402	Association	1029	10964
24742402	Association	MESH:D000544	1029
24742402	Association	MESH:D008545	1029
24742402	Association	1029	3105
24742402	Association	MESH:D002294	1029
24742402	Association	1029	9976
24742402	Association	1029	3115
24742402	Association	1029	3429
24742402	Association	1029	10561
24742402	Association	MESH:D002294	4157
24742402	Association	MESH:D012878	1029
24742402	Association	1029	3431
24742402	Association	MESH:C562393	1029
24742402	Association	MESH:D010300	4157
24742402	Association	MESH:D019636	4157
24742402	Association	MESH:D010300	1029
24742402	Association	MESH:D006816	1029
24742402	Association	1029	56832
24742402	Association	1029	3434
24742402	Association	MESH:D008545	4157
24742402	Association	MESH:D000544	4157
24742402	Association	MESH:C562393	4157

